查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1547565

全球蛋白酶 K 市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Proteinase K Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

全球蛋白酶K市场需求预计将从2023年的49.7亿美元达到近110亿美元的市场规模，2024-2032年研究期间复合年增长率为9.22%。

「蛋白酶 K 是一种具有广谱活性的丝氨酸蛋白酶，广泛应用于分子生物学和生物化学应用中，以消化生物样本中的蛋白质。它在各种 pH 和温度条件下均表现出高活性和稳定性，使其适用于多种蛋白质纯化、萃取和操作程序。它能有效地裂解与色氨酸、苯丙氨酸和蛋氨酸等疏水性氨基酸的羧基相邻的肽键，从而将蛋白质降解为更小的肽和氨基酸。它广泛用于 DNA 和 RNA 萃取、蛋白质消化以及从生物样本中去除核酸酶和其他污染物等技术。

市场动态

分子生物学和生物技术应用对高纯度酵素的需求不断增长，推动了蛋白酶 K 市场的发展。酵素生产和纯化方面的技术进步正在提高蛋白酶 K 的品质和效率，使其更容易用于研究和工业用途。此外，不断扩大的法医学领域严重依赖蛋白酶 K 从复杂的生物样本中分离核酸，进一步推动市场成长。研究经费的增加和政府支持生物技术和生命科学研究的措施也扩大了市场。然而，供应链中断和需求波动可能会阻碍未来几年的市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球蛋白酶 K 市场的各个细分市场进行了包容性评估。

市场区隔

蛋白酶 K 市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按形式

  • 粉末
  • 液体

按治疗领域

  • 传染病
  • 糖尿病
  • 肿瘤学
  • 心臟病学
  • 肾臟病学
  • 自体免疫疾病
  • 神经病学
  • 其他的

按最终用途

  • 基因组 DNA 和 RNA 的分离与纯化
  • 原位杂交
  • 粒线体分离

按申请

  • 合约研究组织
  • 学术机构
  • 生技公司
  • 诊断实验室

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲的蛋白酶 K 市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。蛋白酶K市场的主要参与者包括Merck KGaA、Qiagen、Thermo Fisher Scientific Inc.、F. Hoffmann-La Roche Ltd、Abcam Plc.、Agilent Technologies Inc.、Biocatalysts、Minerva Biolabs GmbH、Promega Corporation、Takara Bio Inc.。 ，新英格兰生物实验室，MP 生物医学。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：蛋白酶 K - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按形式分類的市场吸引力分析
    • 按治疗领域分類的市场吸引力分析
    • 按最终用途分類的市场吸引力分析
    • 市场吸引力分析：依应用分类
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球蛋白酶 K 市场分析：依形式

  • 表格概览
  • 历史和预测资料分析形式
  • 粉末
  • 液体

第 6 章：全球蛋白酶 K 市场分析：按治疗领域

  • 按治疗领域概述
  • 按治疗领域的历史和预测数据分析
  • 传染病
  • 糖尿病
  • 肿瘤学
  • 心臟病学
  • 肾臟病学
  • 自体免疫疾病
  • 神经病学
  • 其他的

第 7 章：全球蛋白酶 K 市场分析：依最终用途分类

  • 按最终用途分类的概述
  • 按最终用途分类的历史和预测资料分析
  • 基因组 DNA 和 RNA 的分离与纯化
  • 原位杂交
  • 粒线体分离

第 8 章：全球蛋白酶 K 市场分析：依应用分类

  • 概述：按应用
  • 历史和预测数据分析：按应用
  • 合约研究组织
  • 学术机构
  • 生技公司
  • 诊断实验室

第 9 章：全球蛋白酶 K 市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 10 章：蛋白酶 K 公司的竞争格局

  • 蛋白酶K市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 11 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Merck KGaA
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Qiagen
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Thermo Fisher Scientific Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • F. Hoffmann-La Roche Ltd
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Abcam Plc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Agilent Technologies Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Biocatalysts
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Minerva Biolabs GmbH
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Promega Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Takara Bio Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • New England Biolabs
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • MP Biomedicals
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR11214810

The global demand for Proteinase K Market is presumed to reach the market size of nearly USD 11 Billion by 2032 from USD 4.97 Billion in 2023 with a CAGR of 9.22% under the study period 2024-2032.

'Proteinase K is a serine protease enzyme with broad-spectrum activity, widely employed in molecular biology and biochemistry applications to digest proteins in biological samples. It exhibits high activity and stability over various pH and temperature conditions, making it suitable for multiple protein purification, extraction, and manipulation procedures. It efficiently cleaves peptide bonds adjacent to the carboxyl group of hydrophobic amino acids, like tryptophan, phenylalanine, and methionine, resulting in the degradation of proteins into smaller peptides & amino acids. It is widely used in techniques such as DNA and RNA extraction, protein digestion, and removal of nucleases and other contaminants from biological samples.

MARKET DYNAMICS

The increasing demand for high-purity enzymes in molecular biology and biotechnological applications drives the proteinase K market. Technological advancements in enzyme production and purification are enhancing the quality and efficiency of proteinase K, making it more accessible for research and industrial uses. Additionally, the expanding field of forensic science relies heavily on proteinase K to isolate nucleic acids from complex biological samples, further driving market growth. Increased research funding and government initiatives supporting biotechnology and life sciences research also expand the market. However, supply chain disruptions and fluctuating demand may hinder market growth in the next few years.'

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Proteinase K. The growth and trends of Proteinase K industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Proteinase K market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Form

  • Powder
  • Liquid

By Therapeutic Area

  • Infectious Diseases
  • Diabetes
  • Oncology
  • Cardiology
  • Nephrology
  • Autoimmune Diseases
  • Neurology
  • Others

By End-use

  • Isolation and Purification of Genomic DNA & RNA
  • In Situ Hybridization
  • Mitochondria Isolation

By Application

  • Contract Research Organization
  • Academic Institutes
  • Biotechnology Companies
  • Diagnostic Laboratories

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Proteinase K market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Proteinase K market include Merck KGaA, Qiagen, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Abcam Plc., Agilent Technologies Inc., Biocatalysts, Minerva Biolabs GmbH, Promega Corporation, Takara Bio Inc., New England Biolabs, MP Biomedicals. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. PROTEINASE K - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Form
    • 3.7.2 Market Attractiveness Analysis By Therapeutic Area
    • 3.7.3 Market Attractiveness Analysis By End-use
    • 3.7.4 Market Attractiveness Analysis By Application
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PROTEINASE K MARKET ANALYSIS BY FORM

  • 5.1. Overview By Form
  • 5.2. Historical and Forecast Data Analysis By Form
  • 5.3. Powder Historic and Forecast Sales By Regions
  • 5.4. Liquid Historic and Forecast Sales By Regions

6. GLOBAL PROTEINASE K MARKET ANALYSIS BY THERAPEUTIC AREA

  • 6.1. Overview By Therapeutic Area
  • 6.2. Historical and Forecast Data Analysis By Therapeutic Area
  • 6.3. Infectious Diseases Historic and Forecast Sales By Regions
  • 6.4. Diabetes Historic and Forecast Sales By Regions
  • 6.5. Oncology Historic and Forecast Sales By Regions
  • 6.6. Cardiology Historic and Forecast Sales By Regions
  • 6.7. Nephrology Historic and Forecast Sales By Regions
  • 6.8. Autoimmune Diseases Historic and Forecast Sales By Regions
  • 6.9. Neurology Historic and Forecast Sales By Regions
  • 6.10. Others Historic and Forecast Sales By Regions

7. GLOBAL PROTEINASE K MARKET ANALYSIS BY END-USE

  • 7.1. Overview By End-use
  • 7.2. Historical and Forecast Data Analysis By End-use
  • 7.3. Isolation and Purification of Genomic DNA & RNA Historic and Forecast Sales By Regions
  • 7.4. In Situ Hybridization Historic and Forecast Sales By Regions
  • 7.5. Mitochondria Isolation Historic and Forecast Sales By Regions

8. GLOBAL PROTEINASE K MARKET ANALYSIS BY APPLICATION

  • 8.1. Overview By Application
  • 8.2. Historical and Forecast Data Analysis By Application
  • 8.3. Contract Research Organization Historic and Forecast Sales By Regions
  • 8.4. Academic Institutes Historic and Forecast Sales By Regions
  • 8.5. Biotechnology Companies Historic and Forecast Sales By Regions
  • 8.6. Diagnostic Laboratories Historic and Forecast Sales By Regions

9. GLOBAL PROTEINASE K MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE PROTEINASE K COMPANIES

  • 10.1. Proteinase K Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF PROTEINASE K INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Merck KGaA
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Qiagen
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Thermo Fisher Scientific Inc.
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. F. Hoffmann-La Roche Ltd
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Abcam Plc.
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Agilent Technologies Inc.
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Biocatalysts
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Minerva Biolabs GmbH
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Promega Corporation
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Takara Bio Inc.
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. New England Biolabs
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. MP Biomedicals
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Form (USD MN)
  • Powder Market Sales By Geography (USD MN)
  • Liquid Market Sales By Geography (USD MN)
  • Analysis By Therapeutic Area (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Diabetes Market Sales By Geography (USD MN)
  • Oncology Market Sales By Geography (USD MN)
  • Cardiology Market Sales By Geography (USD MN)
  • Nephrology Market Sales By Geography (USD MN)
  • Autoimmune Diseases Market Sales By Geography (USD MN)
  • Neurology Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Isolation and Purification of Genomic DNA & RNA Market Sales By Geography (USD MN)
  • In Situ Hybridization Market Sales By Geography (USD MN)
  • Mitochondria Isolation Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Contract Research Organization Market Sales By Geography (USD MN)
  • Academic Institutes Market Sales By Geography (USD MN)
  • Biotechnology Companies Market Sales By Geography (USD MN)
  • Diagnostic Laboratories Market Sales By Geography (USD MN)
  • Global Proteinase K Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Proteinase K Report
  • Market Research Process
  • Market Research Methodology
  • Global Proteinase K Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Form
  • Market Attractiveness Analysis By Therapeutic Area
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Form (USD MN)
  • Powder Market Sales By Geography (USD MN)
  • Liquid Market Sales By Geography (USD MN)
  • Global Market Analysis By Therapeutic Area (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Diabetes Market Sales By Geography (USD MN)
  • Oncology Market Sales By Geography (USD MN)
  • Cardiology Market Sales By Geography (USD MN)
  • Nephrology Market Sales By Geography (USD MN)
  • Autoimmune Diseases Market Sales By Geography (USD MN)
  • Neurology Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Isolation and Purification of Genomic DNA & RNA Market Sales By Geography (USD MN)
  • In Situ Hybridization Market Sales By Geography (USD MN)
  • Mitochondria Isolation Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Contract Research Organization Market Sales By Geography (USD MN)
  • Academic Institutes Market Sales By Geography (USD MN)
  • Biotechnology Companies Market Sales By Geography (USD MN)
  • Diagnostic Laboratories Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.